Letter to the editor : 'Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa'
| Errataetall: |
CommentIn: Expert Opin Emerg Drugs. 2022 Dec;27(4):449-450. - PMID 36562394 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Expert opinion on emerging drugs - 27(2022), 4 vom: 25. Dez., Seite 445-447 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Georgiadis, Anastasios [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 26.12.2022 Date Revised 06.01.2023 published: Print CommentIn: Expert Opin Emerg Drugs. 2022 Dec;27(4):449-450. - PMID 36562394 Citation Status MEDLINE |
|---|
| doi: |
10.1080/14728214.2022.2152202 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM350739137 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM350739137 | ||
| 003 | DE-627 | ||
| 005 | 20231226045656.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/14728214.2022.2152202 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1169.xml |
| 035 | |a (DE-627)NLM350739137 | ||
| 035 | |a (NLM)36562396 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Georgiadis, Anastasios |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Letter to the editor |b 'Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa' |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.12.2022 | ||
| 500 | |a Date Revised 06.01.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Expert Opin Emerg Drugs. 2022 Dec;27(4):449-450. - PMID 36562394 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Eye Proteins |2 NLM | |
| 650 | 7 | |a RPGR protein, human |2 NLM | |
| 700 | 1 | |a Smith, Alexander J |e verfasserin |4 aut | |
| 700 | 1 | |a Michaelides, Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Naylor, Stuart |e verfasserin |4 aut | |
| 700 | 1 | |a Forbes, Alexandria |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on emerging drugs |d 2001 |g 27(2022), 4 vom: 25. Dez., Seite 445-447 |w (DE-627)NLM143290835 |x 1744-7623 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2022 |g number:4 |g day:25 |g month:12 |g pages:445-447 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/14728214.2022.2152202 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2022 |e 4 |b 25 |c 12 |h 445-447 | ||